Table 4.
Multivariate Cox regression models for cardiovascular mortality
| Variable | MVC | AVC | ||
|---|---|---|---|---|
| HR(95%) | P | HR(95%) | P | |
| mitral or aortic valve calcification | 2.340 (1.625–3.370) | <0.001 | 2.410 (1.632–3.559) | <0.001 |
| Age | 1.015 (1.000–1.030) | 0.056 | 1.010 (0.994–1.026) | 0.223 |
| Diabetes | 2.538 (1.747–3.688) | <0.001 | 2.195 (1.507–3.197) | <0.001 |
| CVD | 2.284 (1.535–3.398) | <0.001 | 2.141 (1.443–3.179) | <0.001 |
| Phosphorus-binding medications | 0.847 (0.543–1.319) | 0.462 | 0.952 (0.602–1.505) | 0.832 |
| Vitamin D medications | 0.579 (0.389–0.864) | 0.007 | 0.602 (0.403–0.899) | 0.013 |
| LAD | 1.977 (1.353–2.889) | 0.001 | 2.157 (1.455–3.197) | 0.001 |
| LVMI | 0.997 (0.991–1.003) | 0.282 | 0.996 (0.990–1.002) | 0.207 |
| EF | 0.597 (0.080–4.438) | 0.615 | 0.872 (0.108–7.031) | 0.897 |
| HGB | 0.987 (0.976–0.998) | 0.018 | 0.986 (0.975–0.997) | 0.016 |
| β2-Microglobulin | 1.018 (0.994–1.044) | 0.145 | 1.035 (1.010–1.061) | 0.007 |
| ALB | 0.978 (0.928–1.032) | 0.420 | 0.990 (0.940–1.042) | 0.691 |